. 2019 Dec 9;19(2):1024–1032. doi: 10.3892/etm.2019.8305

Table VI.

Important clinical events of patients with ATIII.

Days	ATIII ≥66.95% n=41	ATIII <66.95% n=28	P-value	χ²-value
HLOS	14.87±10.62	18.40±15.14	0.361	−0.922
ICU hospital stay	9.81±5.78	20.80±15.89	0.020^a	−2.599
Duration of no vasoactive drug use	26.36±4.48	16.87±13.29	0.088	1.940
No mechanical ventilation time	25.09±4.61	13.12±14.12	0.049^a	2.310
No CRRT time	26.46 ±5.13	15.50±12.76	0.048^a	2.297
Survival time	24.73±6.51	18.78±10.99	0.014^a	2.572

ICULOS, intensive care unit length of stay; HLOS, hospital length of stay; CRRT, continuous renal replacement therapy; AKI, acute kidney injury; ATIII, antithrombin III; OR, odds ratio; CI, confidence interval.

P<0.05.